Snowball logo
logo
4161

Bioptik Technology

4161 โ€ข TWO
NT$22.90NT$0.00ย  (0%)
Estimate
P/E
18.2
EPS
1.26
Beta
0.256
Growth
Revenue, YoY
14.6%
Net income, YoY
18.61%
FCF, YoY
-157.14%
Dividends
Dividend yield
3.06%
Annual payout
NT$0.70
Next ex. div date
July 16, 27
Payout
22.31%
Div.growth, 5y
-9.91%
Dividend growth streak
1 year
Div.rating
About the company
Ticker
4161
ISIN
TW0004161005
Country
Taiwan
Sector (GICS)
Healthcare
Bioptik Technology Incorporation engages in the manufacturing, wholesale, and retail of biotechnology and medical equipment in Taiwan and internationally. The company offers blood glucose, cholesterol, uric acid, hemoglobin and acid multi-function monitoring systems under the EasyMate, EasySure, and EasyTouch brand name, as well as PeTouch, a glucose monitoring system for dogs and cats. It also provides dietary supplements, such as capsules, gel capsules, tablets, solutions, powder sachet, jelly, and gummy; cosmetic products, including sunscreen, cream/lotion, make-up removal, shampoo, time capsule, and toner/essence; and skin care products. In addition, the company is involved in manufacturing feed, canned food, and food additive, aircraft and parts, and chemicals; wholesale and import and export trade of cosmetics raw materials, semi-finished products and finished products; cosmetics retail and wholesale; and special forestry management. Bioptik Technology Incorporation was founded in 1999 and is based in Zhunan, Taiwan.

Frequently asked questions

What sector does Bioptik Technology (4161) operate in?

Bioptik Technology belongs to the Healthcare sector and operates in the Medical Devices industry.

What is Bioptik Technology (4161) current stock price?

As of the latest data, Bioptik Technology stock price is NT$22.90, with a previous close of NT$22.90.

What is Bioptik Technology (4161) current market capitalization?

Bioptik Technology market cap is approximately 1.37 billion.

What is Bioptik Technology (4161) Earnings Per Share (EPS)?

The trailing EPS is NT$1.26.

What is Bioptik Technology (4161) Price-to-Earnings (P/E) ratio?

Bioptik Technology current P/E ratio is 18.17.

Does Bioptik Technology (4161) pay dividends?

Yes. Bioptik Technology pays annual dividends with an annualized yield of 3.06% and an estimated annual payout of NT$0.70 per share.

When is the next ex-dividend date for Bioptik Technology (4161)?

The next ex-dividend date is scheduled for July 16, 2027.

What is Bioptik Technology (4161) beta (volatility) score?

Bioptik Technology has a beta of 0.256, indicating lower volatility than the overall market.